Systematic review of Mendelian randomization studies on Parkinson's disease

Sophia Kappen1, Daniele Bottigliengo2, Amke Caliebe3,4

  • 1Institute of Medical Biometry and Statistics, University of Lübeck, University Hospital Schleswig-Holstein, Ratzeburger Allee 160, 23562 Lübeck, Germany.

Abstract

Insights

Mendelian randomization studies help identify non-genetic causes of Parkinson's disease (PD). This review found most studies were well-conducted, aiding future PD prevention and early intervention research.

Area of Science:

  • Neuroscience
  • Genetics
  • Epidemiology

Background:

  • Parkinson's disease (PD) is linked to non-genetic risk factors.
  • Mendelian randomization (MR) is a powerful genetic epidemiology tool to infer causality.
  • MR utilizes genetic variants as instrumental variables for risk factors, minimizing confounding.

Purpose of the Study:

  • To systematically review Mendelian randomization (MR) studies investigating Parkinson's disease (PD).
  • To evaluate the methodological quality and summarize evidence from existing MR research on PD.
  • To identify causal exposures relevant to PD etiology and prevention.

Main Methods:

  • A systematic literature search was conducted in the PubMed database.
  • Data extraction and quality assessment were performed on identified MR studies.
  • Evidence synthesis focused on identifying significant associations and methodological rigor.

Main Results:

  • Twelve articles met the inclusion criteria for the systematic review.
  • Most included studies demonstrated good methodological quality.
  • Twelve analyses reported nominally significant effects, suggesting potential causal links.

Conclusions:

  • MR studies are valuable for identifying causal exposures related to Parkinson's disease.
  • The findings support the utility of MR in guiding future research on PD prevention and early intervention.
  • Well-conducted MR studies can significantly advance our understanding of PD etiology.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
527
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
257
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.3K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.9K